Bosutinib in Elderly Chronic Myeloid Leukemia

Summary

The objective of the present study is to evaluate a new drug called bosutinib as it is believed that this agent may be able to predict an excellent prognosis in patients that did not obtain any benefit with other drugs before. Still, this needs to be proved and we hope this study is able to do so.

Timeline

Start

2016-11-17

Primary completion

2020-04-30

Completion

2022-06-22

Drugs

Indications